DONGSUNG CHEMICAL Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	1,213,228	1,211,600	1,066,318	993,004	1,140,124	925,979
Revenue	1,213,228	1,211,600	1,066,318	993,004	1,140,124	925,979
Revenue Growth (YoY)	10.45%	13.63%	7.38%	-12.90%	23.13%	7.17%
Cost of Revenue	982,677	986,870	870,805	830,399	995,688	789,984
Gross Profit	230,551	224,729	195,513	162,605	144,435	135,994
Selling, General & Admin	98,845	97,707	91,906	80,133	82,106	81,787
Research & Development	4,488	4,510	3,175	2,535	2,285	1,793
Amortization of Goodwill & Intangibles	933.15	868.38	872.5	1,075	1,154	893.16
Other Operating Expenses	2,625	2,517	2,027	1,516	1,459	1,632
Operating Expenses	114,266	112,650	104,571	88,534	89,239	92,435
Operating Income	116,285	112,079	90,942	74,071	55,196	43,559
Interest Expense	-5,460	-5,397	-4,555	-8,603	-5,382	-5,362
Interest & Investment Income	3,519	3,499	3,336	7,007	4,554	1,804
Earnings From Equity Investments	-9,006	-8,743	-72.84	-5,073	-4,420	-1,531
Currency Exchange Gain (Loss)	-1,610	-5,381	7,357	1,450	7,602	6,192
Other Non Operating Income (Expenses)	2,493	3,782	-2,612	46.02	-6,385	7,809
EBT Excluding Unusual Items	106,221	99,839	94,394	68,897	51,164	52,472
Gain (Loss) on Sale of Investments	-563.19	-635.03	-4,193	-3,348	5,221	2,640
Gain (Loss) on Sale of Assets	-439.27	-282.32	-1,193	-1,734	-357.8	1,146
Asset Writedown	-762.84	-762.84	-	-	-255.26	-2,622
Pretax Income	104,456	98,159	89,009	63,815	55,773	53,636
Income Tax Expense	22,213	22,602	27,811	9,213	8,940	12,196
Earnings From Continuing Operations	82,243	75,557	61,198	54,602	46,833	41,440
Earnings From Discontinued Operations	-	-	16,783	4,113	-	951.72
Net Income to Company	82,243	75,557	77,981	58,715	46,833	42,392
Minority Interest in Earnings	-46,593	-42,307	-33,030	-25,261	-11,792	-24,479
Net Income	35,650	33,250	44,951	33,454	35,041	17,913
Net Income to Common	35,650	33,250	44,951	33,454	35,041	17,913
Net Income Growth	-15.65%	-26.03%	34.37%	-4.53%	95.62%	168.43%
Shares Outstanding (Basic)	49	49	49	50	50	49
Shares Outstanding (Diluted)	50	50	50	50	51	50
Shares Change (YoY)	0.33%	-0.04%	-1.08%	-0.92%	1.21%	10.47%
EPS (Basic)	722.63	675.57	914.54	673.95	699.74	363.91
EPS (Diluted)	719.17	672.00	907.92	668.38	694.05	359.23
EPS Growth	-15.90%	-25.99%	35.84%	-3.70%	93.21%	143.29%
Free Cash Flow	24,031	55,343	-715.98	82,648	18,493	-34,007
Free Cash Flow Per Share	484.60	1118.03	-14.46	1650.98	366.04	-681.25
Dividend Per Share	149.010	149.010	49.505	196.059	196.059	196.059
Dividend Growth	201.00%	201.00%	-74.75%	-	-	-20.00%
Gross Margin	19.00%	18.55%	18.34%	16.38%	12.67%	14.69%
Operating Margin	9.59%	9.25%	8.53%	7.46%	4.84%	4.70%
Profit Margin	2.94%	2.74%	4.22%	3.37%	3.07%	1.93%
Free Cash Flow Margin	1.98%	4.57%	-0.07%	8.32%	1.62%	-3.67%
EBITDA	152,970	147,700	116,708	100,506	78,649	69,262
EBITDA Margin	12.61%	12.19%	10.95%	10.12%	6.90%	7.48%
D&A For EBITDA	36,684	35,621	25,767	26,435	23,452	25,703
EBIT	116,285	112,079	90,942	74,071	55,196	43,559
EBIT Margin	9.59%	9.25%	8.53%	7.46%	4.84%	4.70%
Effective Tax Rate	21.27%	23.03%	31.25%	14.44%	16.03%	22.74%